home

Breaking News

Redox Signs Licensing Agreement With OPKO Health, Inc.
On June 12, 2008, OPKO and Redox entered into an agreement whereby OPKO acquired the rights for all ophthalmic uses of Doxovir.

see OPKO Press Release

Redox Pharmaceutical Corporation has been granted approval from Health Canada to perform clinical studies on Herpes Labialis (cold sores).  Phase IB Clinical Trials (initial proof of safety and efficacy) have been successfully completed. A Phase II Clinical Trial on Herpes Labialis has been approved and has now been initiated.


©2008 Redox Pharmaceutical Corporation.
All right reserved.

Send us your site suggestions & service requests.

Site hosted by: Transbeam.com

MANAGEMENT AND BOARD OF DIRECTORS

Melvin Dubin, Chairman of the Board of Directors, Founder and Chairman of the Board of Slant/Fin Corporation, established in 1949, a heating products manufacturer with factories in U.S. and Canada. Mr. Dubin is Chairman of Modulation Optics, manufacturers of optical systems for enhancement of microscope images.

Dr. David Gershon, Senior Vice President, Chief Scientific Officer and Director, was Skillman Professor and Chairman of the Department of Biology at the Technion - Israel Institute of Technology. Dr. Gershon received his Ph.D. from Cornell University. His expertise includes genetics, virology (particularly tumor virology), and molecular and cellular aging processes. His ideas on the use of small molecules to mimic larger enzymes were the basis for the development of Redox's family of CTC compounds. Dr. Gershon is the author of over 100 scientific publications and two books and numerous articles for lay people. Dr. Gershon has been chairman of many scientific symposia and has been an active member of numerous academic national and international committees on basic science and biotechnology.

Donald Brown, Chief Financial Officer and Director, Vice Chairman of Slant/Fin Corporation, a graduate of New York University School of Business, began his career in public accounting as a Certified Public Accountant. Mr. Brown has served as a member of the Small Business Advisory Council of the Federal Reserve Bank of New York.

Ephraim Ruttner, Chief Operating Officer and Director, graduated Cornell University with a degree in Biology and did extensive graduate work in Pharmacology at Cornell Graduate School of Medical Sciences. Mr. Ruttner co-founded Direct-Page Communications, Inc., a Radio Common Carrier with transmission facilities in upstate New York, and Starlite Contractors Corporation, an energy management company.

Mitchel Ruttner, Director.   Mitchel Ruttner is a co founder and partner of     R & R Publishing Group, Inc.

Robert Sterling, Director, is a co-founder and President of the Stockbridge Group, a risk management and employee benefits consulting firm. Mr. Sterling has provided pro-bono consulting for and served on the Board of several not-for-profit institutions. R. Sterling holds a Bachelors degree in Science and Business Administration from Boston University and received his ARM designation from The American Institute for Property and Liability Underwriters.

Dr. Steven Turner, Director.   Dr. Steven S. Turner is a general dentist and has been practicing in Howard Beach, NY since 1979. Dr. Turner has a BA from Queens College of CUNY, and a DDS from the NYU College of Dentistry. Besides being an active clinician, Dr. Turner is a paid consultant for the Gerson Lehrman Group, and was a consultant to Lenny Dykstra for his startup company, The Players Club.

top

Contact Us | Home

SEE ALSO

Our Company

Intellectual
Property
and Awards

 

 

Melvin Dubin
Dr. David Gershon
Donald Brown
Ephraim Ruttner
Mitchel Ruttner
Robert Sterling
Dr. Steven Turner